rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2003-5-13
|
pubmed:abstractText |
We sought to assess whether hyperenhancement by gadolinium cardiovascular magnetic resonance (CMR) occurs in hypertrophic cardiomyopathy (HCM) and correlates with the risk of heart failure and sudden death.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0735-1097
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1561-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12742298-Adolescent,
pubmed-meshheading:12742298-Adult,
pubmed-meshheading:12742298-Aged,
pubmed-meshheading:12742298-Cardiomyopathy, Hypertrophic,
pubmed-meshheading:12742298-Contrast Media,
pubmed-meshheading:12742298-Death, Sudden, Cardiac,
pubmed-meshheading:12742298-Female,
pubmed-meshheading:12742298-Gadolinium DTPA,
pubmed-meshheading:12742298-Heart Failure,
pubmed-meshheading:12742298-Humans,
pubmed-meshheading:12742298-Magnetic Resonance Imaging,
pubmed-meshheading:12742298-Male,
pubmed-meshheading:12742298-Middle Aged,
pubmed-meshheading:12742298-Predictive Value of Tests,
pubmed-meshheading:12742298-Prospective Studies,
pubmed-meshheading:12742298-Risk Assessment,
pubmed-meshheading:12742298-Severity of Illness Index
|
pubmed:year |
2003
|
pubmed:articleTitle |
Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.
|
pubmed:affiliation |
Centre for Advanced Magnetic Resonance in Cardiology (CAMRIC), Royal Brompton Hospital, London, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|